Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT

BACKGROUND: Paclitaxel has shown significant anti-tumor activity against non-small cell lung cancer (NSCLC); however, resistance to paclitaxel frequently occurs and represents a significant clinical problem and its underlying molecular mechanism remains elusive. METHODS: Long-term treatment of cultu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yuanming, Jia, Ruxue, Xiong, Haozhe, Ren, Qun, Zuo, Weimin, Lin, Tingting, Lin, Rong, Lei, Yan, Wang, Ping, Dong, Huiyue, Zhao, Hu, Zhu, Ling, Fu, Yunfeng, Zeng, Zhiyong, Zhang, Wei, Wang, Shuiliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689126/
https://www.ncbi.nlm.nih.gov/pubmed/31496800
http://dx.doi.org/10.2147/CMAR.S215427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689126/
https://www.ncbi.nlm.nih.gov/pubmed/31496800
http://dx.doi.org/10.2147/CMAR.S215427

Ejemplares similares